Trade Tracker: Rob Sechan sells Bristol Myers and buys more Abbvie YouTube Trade Tracker: Rob Sechan sells Bristol Myers and buys more Abbvie. AbbVie (ABBV) Bristol 2 months
Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It? Investor's Business Daily 2 days
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough CNBC 3 days
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It Zacks 3 days
The Zacks Analyst Blog Highlights Visa, AbbVie, Anheuser-Busch, Servotronics and United-Guardian Zacks 1 week
Bristol Myers Squibb: Momentum Still Promising Through H2 2024, Turnaround Likely Prolonged Seeking Alpha 1 week
Bristol-Myers Squibb: Shares Getting Closer To The Tipping Point (Rating Downgrade) Seeking Alpha 2 weeks
Bristol-Myers Squibb: A Better Earnings Outlook, Stronger Momentum Heading Into 2025 Seeking Alpha 2 weeks
Bristol-Myers Squibb Company (BMY) Wells Fargo 2024 Healthcare Conference (Transcript) Seeking Alpha 2 weeks
Bristol Myers Squibb (BMY) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks 2 weeks
Is Bristol-Myers Squibb Company (BMY) The Best Beaten Down Dividend Stocks to Invest in Now? Insider Monkey 2 weeks
Bristol-Myers Squibb Company (BMY) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript) Seeking Alpha 2 weeks
2 Reasons Bristol Myers Squibb Stock Could Be a Bargain, Down 34% From Its All-Time High The Motley Fool 2 weeks
How To Put $100 In Your Retirement Fund Each Month With Bristol-Myers Squibb Stock Yahoo Finance 3 weeks
The forgotten pharma stocks left in the dust by Eli-Lilly could be primed for a comeback CNBC 3 weeks
Abbvie (ABBV) has been the biggest surprise in my portfolio, up 22% YTD with a 3% div. What’s been a surprise stock in your portfolio? Reddit 4 weeks
3 High-Yield Stocks to Buy Now That Have Increased Their Dividends for 25 Years or More The Motley Fool 1 month
AbbVie Inc. (ABBV): Among the Best Cosmetic Surgery and Aesthetics Stocks To Buy Now Insider Monkey 1 month
Largest U.K. stock broker accepts £5.4 billion bid from private equity consortium including CVC MarketWatch 1 month